Taxotere is the brand name for the cancer medicine docetaxel. Generic versions of the drug are also available. Taxotere has been approved to treat a variety of cancers, including breast cancer, lung cancer, stomach cancer and head and neck cancer. Administered by infusion, Taxotere is a powerful drug with a long list of side effects. While many cancer treatments may result in temporary hair loss, the use of Taxotere can cause permanent hair loss.1 Because Sonofi, the company that first manufactured Taxotere did not make this  side effect known when the drug was brought to market, patients who have suffered permanent hair loss have brought lawsuits against the company. Lawsuits have also been filed against manufacturers of generic versions of the drug.

Manufacturers did not begin warning of the risk of permanent hair loss until the drug had been on the market for many years.2 Other drugs that do not cause permanent hair loss have been shown to be as effective as Taxotere. If you have suffered permanent hair loss due to the use of Taxotere or a generic version of the drug, please contact us to discuss your situation.

Settlement funds may be available to you.

Call for a free consultation to qualify:(615) 560-6552

Sources:

1 Sedlacek, SM. Persistent significant alopecia (PSA) from adjuvant docetaxel after doxorubicin/cyclophosphamide (AC) chemotherapy in women with breast cancer. Rocky Mountain Cancer Centers, Denver, CO. Presented, San Antonio Breast Cancer Symposium, San Antonio, TX, Dec. 14-17, 2006.

2McElrath, KJ. Taxotere Permanent Hair Loss Warnings Were Issued In The E.U. Ten Years Earlier Than In The U.S. Why? Drugssafetynews.com. July 3, 2018.